Home / Digestive tract and metabolism / Aprepitant
ATC A04AD12 · Antiemetics and Antinauseants
Aprepitant shortage
As of 31 Oct 2026, Aprepitant has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Austria), covering 15 products.
Countries4/5
Products15packs or presentations
Short since15 Jan 20242.8 years ago
Earliest return31 Oct 2026company estimate
No return date3products
Main reasonManufacturing problem
Timeline
GermanyItalySpainAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Aprepitant AL 125 mg Hartkapseln | ALIUD PHARMA GmbH | 1 Aug 2024 | 8 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Aprepitant STADA 125 mg und 80 mg Hartkapseln | STADAPHARM GmbH | 5 Aug 2024 | 14 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Aprepitant AL 80 mg Hartkapseln | ALIUD PHARMA GmbH | 1 Nov 2024 | 11 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Aprepitant STADA 125 mg Hartkapseln | STADAPHARM GmbH | 17 Feb 2025 | 14 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Aprepitant AL 125 mg und 80 mg Hartkapseln | ALIUD PHARMA GmbH | 1 Sep 2025 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Aprepitant Zentiva 80 mg und 125 mg Hartkapseln | Zentiva Pharma GmbH | 1 Oct 2025 | 30 Apr 2027 | Manufacturing problem Probleme in der Herstellung |
| IT | APREPITANT ACCORD | ACCORD HEALTHCARE, S.L.U. | 15 Jan 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | ATANTO | GLENMARK PHARMA S.R.L. | 5 May 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | FOSAPREPITANT ACCORD | ACCORD HEALTHCARE, S.L.U. | 19 Oct 2026 | not given | Increased demand Elevata richiesta |
| IT | IVEMEND announced | MERCK SHARP & DOHME B.V. | 7 Nov 2026 | 31 Mar 2027 | Manufacturing problem Problemi produttivi |
| ES | APREPITANT ACCORD 125 MG CAPSULAS DURAS EFG/APREPITANT ACCORD 80 MG CAPSULAS DURAS EFG, 1 cápsula de 125 mg + 2 cápsulas de 80 mg | Accord Healthcare S.L.U. | 10 Jul 2024 | 30 Jul 2027 | Not stated |
| ES | IVEMEND 150 MG POLVO PARA SOLUCION PARA PERFUSION , 1 vial | Merck Sharp & Dohme B.V. | 24 Sep 2026 | 31 Mar 2027 | Not stated |
| AT | Aprepitant Accord 125 mg Hartkapseln, 5 Stück | Accord Healthcare B.V. | 1 Feb 2026 | 31 Oct 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Aprepitant Accord 80 mg Hartkapseln, 2 Stück limited | Accord Healthcare B.V. | 1 Feb 2026 | 31 Oct 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Aprepitant Accord 80 mg Hartkapseln, 5 Stück limited | Accord Healthcare B.V. | 1 Feb 2026 | 31 Oct 2026 | Manufacturing problem Verzögerung bei der Herstellung |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.